These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9288063)

  • 21. Renoprotective role of ACE inhibitors in diabetic nephropathy.
    Mogensen CE
    Br Heart J; 1994 Sep; 72(3 Suppl):S38-45. PubMed ID: 7946802
    [No Abstract]   [Full Text] [Related]  

  • 22. Renoprotection with antihypertensive agents.
    Fournier A; Presne C; Makdassi R; Mazouz H; Choukroun G
    Lancet; 2002 May; 359(9318):1694-5. PubMed ID: 12020553
    [No Abstract]   [Full Text] [Related]  

  • 23. Optimal dosing of renin-angiotensin-aldosterone system blockers for renal protection: a solved issue?
    Laverman GD; Bakker SJ; Navis GJ
    Diabetologia; 2009 Jun; 52(6):1217-8. PubMed ID: 19294362
    [No Abstract]   [Full Text] [Related]  

  • 24. Controversies on the prevention of diabetic nephropathy.
    Chiarelli F; Verrotti A; Basciani F; di Ricco L; Sabatino G; Morgese G
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.
    Gagliardini E; Corna D; Zoja C; Sangalli F; Carrara F; Rossi M; Conti S; Rottoli D; Longaretti L; Remuzzi A; Remuzzi G; Benigni A
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1448-56. PubMed ID: 19675181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and their combination on microalbuminuria in normotensive patients with type 2 diabetes.
    Atmaca A; Gedik O
    Adv Ther; 2006; 23(4):615-22. PubMed ID: 17050503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preserving the diabetic kidney.
    Poirier SJ
    J Fam Pract; 1998 Jan; 46(1):21-7. PubMed ID: 9451365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACE inhibitors and antihypertensive treatment in diabetes: focus on microalbuminuria and macrovascular disease.
    Mogensen CE
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):234-9. PubMed ID: 11881030
    [No Abstract]   [Full Text] [Related]  

  • 29. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should Angiotensin converting enzyme inhibitors be used in children with type 1 diabetes and microalbuminuria?
    Almerie MQ; Williams RM; Acerini CL
    Arch Dis Child; 2008 Jul; 93(7):633-5. PubMed ID: 18285389
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention of microalbuminuria in type 2 diabetics.
    Maritz FJ
    Cardiovasc J S Afr; 2005; 16(1):68-70. PubMed ID: 15778784
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACE inhibitors and diabetic nephropathy.
    Molitch ME
    Diabetes Care; 1994 Jul; 17(7):756-60. PubMed ID: 7924789
    [No Abstract]   [Full Text] [Related]  

  • 34. Renoprotection in diabetes: genetic and non-genetic risk factors and treatment.
    Parving HH
    Diabetologia; 1998 Jul; 41(7):745-59. PubMed ID: 9686914
    [No Abstract]   [Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.
    Poulsen PL
    J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):17-26. PubMed ID: 12692749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
    Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P
    Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The kidney in diabetes: how to control renal and related cardiovascular complications.
    Mogensen CE
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S2-6. PubMed ID: 11158852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential pharmacodynamic drug-drug interaction between concomitantly administered lisinopril and diclofenac sodium: a call for appropriate management in hypertensive osteoarthritic patients.
    Goswami SK; Jain S; Chudasama H; Santani D
    Drug Metabol Drug Interact; 2011; 26(3):127-37. PubMed ID: 21980964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Should normotensive diabetic patients with microalbuminuria be treated with angiotensin converting enzyme inhibitors?].
    Feldt-Rasmussen BF
    Ugeskr Laeger; 2002 Apr; 164(14):1907-9. PubMed ID: 11957423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.